Etazolate improves performance in a foraging and homing task in aged rats.
Jason Drott, L Desire, D Drouin, M Pando, Forrest Haun
Index: Eur. J. Pharmacol. 634(1-3) , 95-100, (2010)
Full Text: HTML
Abstract
Etazolate is a phosphodiesterase 4 (PDE4) inhibitor and GABAA receptor modulator that also stimulates alpha-secretase activity and neurotrophic soluble amyloid precursor protein (sAPPalpha) production, currently developed as a possible Alzheimer's disease therapeutic. In this study two doses of etazolate were tested for cognitive effects in normally aged rats, using a complex spatial learning and memory task that emphasized two naturally occurring behaviors in rodents, foraging for food and returning large pieces of found food to a safe home location. Both etazolate doses completely prevented both (1) a foraging deficit that developed in untreated aged rats over the course of the test, as well as (2) a trial-specific deficit in memory for previously visited food locations that also developed over the course of the test in untreated aged rats. Both doses also significantly reduced a separate memory deficit for changing locations of the animals' home box, plus completely prevented a significant tendency for untreated aged animals to attempt entry into similar-appearing but incorrect home boxes. The combined behavioral data demonstrate positive effects of etazolate on separate age-related cognitive deficits, using a complex task based on naturally occurring rodent behaviors.Copyright 2010 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve.
1984-03-01
[J. Pharmacol. Exp. Ther. 228(3) , 656-61, (1984)]
[Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
1984-01-01
[Ann. Pharm. Fr. 42(2) , 99-112, (1984)]
TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi.
2006-01-01
[Mol. Biochem. Parasitol. 145(1) , 40-9, (2006)]
1987-11-01
[J. Neurochem. 49(5) , 1491-7, (1987)]
1984-01-01
[Prog. Neuropsychopharmacol. Biol. Psychiatry 8(4-6) , 785-8, (1984)]